“If an evil has been pondered beforehand, the blow is gentle when it comes.” – Seneca, Moral Letters to Lucilius
Before starting any new treatment, I always ask myself one question: What is the worst possible thing that could happen here?
As both a physician and a patient, I understand that the unknown can feel intimidating. Medications like tirzepatide (Zepbound) can be powerful tools for improving health, but they can also bring challenges. That’s why I prefer to bring everything into the light, examine it carefully, understand it fully, and prepare for it intelligently.
In this guide, I’ll walk you through the side effects and risks of GLP-1 medications such as tirzepatide and semaglutide (Zepbound, Mounjaro, Ozempic, Wegovy, Rybelsus, etc.). You’ll learn not only what to expect but why these effects happen and how to manage them safely and effectively.
🔑 Key takeaways
|
What are the most common side effects of GLP-1 medications?
The most frequent side effects of GLP-1 medications occur in more than 10% of patients. These include:
- Nausea
- Constipation
- Diarrhea
- Vomiting
- Abdominal pain or discomfort
Although nobody wants to spend the day in the bathroom or feeling nauseated, these side effects are usually benign and temporary. They tend to lessen over time as your body adjusts to the medication.
Knowing why they happen helps reduce the fear that often comes with new symptoms.
These medications work by slowing down your gastrointestinal (GI) tract, essentially, your body’s plumbing system. Your GI tract is one continuous “pipe” from your mouth to your bottom. When it slows down, things can start to back up. Food moves more slowly through the system, which leads to feelings of fullness, bloating, nausea, or constipation. In other cases, the imbalance can cause diarrhea or even vomiting.
In short, the same mechanism that helps you eat less and feel satisfied longer can also cause temporary digestive discomfort.
Why “start low and go slow” matters
In my telehealth practice, patients have direct access to our messaging platform and app. This allows us to address side effects immediately and adjust treatment as needed.
The good news is that these side effects are dose-dependent. That means they are more likely when you start too high or increase your dose too quickly. Over time, your body adapts, and the side effects typically diminish.
This is why I always tell patients: start low and go slow.
Rushing your dose escalation doesn’t lead to faster results, it just increases your chance of discomfort.
When should you call your doctor or go to the ER?
Most side effects are mild and manageable at home, but there are specific warning signs that should never be ignored.
- Severe or continuous diarrhea and vomiting
If you have nonstop diarrhea or vomiting, you could become severely dehydrated. Dehydration can harm the kidneys and, in rare cases, lead to acute kidney injury.
The medication itself rarely causes direct kidney damage. The issue arises because the kidneys are extremely sensitive to fluid loss. When dehydration sets in, blood flow to the kidneys drops, leading to temporary kidney failure.
Although that sounds frightening, it’s usually reversible when caught early. Treatment often involves hospitalization, IV hydration, and close monitoring of lab values. However, if ignored, it can become dangerous, even life-threatening.
- Severe or persistent abdominal pain
Pain in your abdomen is never normal. Mild or moderate cramping that fades within an hour is not usually concerning. But pain that intensifies or lasts for several hours can indicate something more serious.
If you experience ongoing, severe, or worsening abdominal pain, contact your doctor or go to the emergency room immediately.
- Constipation and related Symptoms
Constipation is rarely a medical emergency, but it can feel miserable. I recommend a standard bowel regimen for every patient beginning GLP-1 therapy. It’s best to start this on day one and continue it consistently. Preventing constipation is much easier than treating it after it becomes severe.
If you notice that your bowel movements are less frequent, that’s often normal, especially if you’re eating less. However, if constipation comes with pain, nausea, abdominal swelling, or discomfort, that’s a red flag. Those symptoms mean it’s time to call your doctor or get checked in person.
Final words
Side effects from tirzepatide and other GLP-1 medications are usually temporary, predictable, and manageable. Most patients tolerate these medications well when dosing is gradual and hydration is maintained.
Pay attention to your body. Stay in communication with your healthcare provider. And remember: being informed and proactive makes the journey safer and far more comfortable.
In the next part of this series, we’ll take a closer look at how to manage each specific side effect, starting with nausea, one of the most common issues patients experience early on.
Sources
- Kim, J. A., & Yoo, H. J. (2025). Exploring the side effects of GLP-1 receptor agonist: To ensure its optimal positioning. Diabetes & Metabolism Journal, 49(4), 525–541. https://doi.org/10.4093/dmj.2025.0242
- Ghusn, W., & Hurtado, M. D. (2024). Glucagon-like receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks. Obesity Pillars, 12, 100127. https://doi.org/10.1016/j.obpill.2024.100127
- Borkum, M., Lau, W., Blanco, P., & Farah, M. (2022). Semaglutide-associated acute interstitial nephritis: A case report. Kidney Medicine, 4(12), 100561. https://doi.org/10.1016/j.xkme.2022.100561
- Dong, S., & Sun, C. (2022). Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data. Frontiers in Endocrinology, 13, 1032199. https://doi.org/10.3389/fendo.2022.1032199
- Rahman, M., Shad, F., & Smith, M. C. (2012). Acute kidney injury: A guide to diagnosis and management. American Family Physician, 86(7), 631–639. Retrieved from https://www.aafp.org/pubs/afp/issues/2012/1001/p631.html
- Goyal, A., Daneshpajouhnejad, P., Hashmi, M. F., & Bashir, K. (2023). Acute kidney injury. In StatPearls [Internet]. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK441896/
Author Bio: Dr. Adrian Blackwell is the founder and CEO of PonteVita Rx, a telehealth practice dedicated to making medication access simpler, more affordable, and less stressful. Licensed to practice medicine in all 50 states and DC, Dr. Blackwell is board certified in obesity medicine and emergency medicine. He combines clinical expertise with personal experience navigating the healthcare system as a patient and parent to children with chronic illnesses. His mission: ensure everyone has access to their necessary medications without unnecessary barriers.
Medical Disclaimer: All the information here, on these videos, YouTube, social media, or in any other format, is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your personal physician or other qualified health provider with any questions you may have regarding a medical condition. Never replace professional medical advice given to you personally or delay in seeking it because of something you have read or heard on this website. This information is not meant to diagnose, treat, or cure any medical condition. No patient-physician relationship is formed. If you’re my patient, please text me before you make any changes to your medication. If you believe you are having a medical emergency please call 911.